Birth control pill recalls show 'weak link in chain' - Action News
Home WebMail Thursday, November 14, 2024, 04:37 PM | Calgary | 6.6°C | Regions Advertise Login | Our platform is in maintenance mode. Some URLs may not be available. |
Health

Birth control pill recalls show 'weak link in chain'

Recent recalls of birth control pills in Canada reveal a lack of due diligence in the production process, a provincial pharmacy group says.

Integrity of federal drug system questioned by Ontario Pharmacists Association

Recent recalls of birth control pills in Canada reveal a lack of due diligence in the production process, a provincial pharmacy group says.

Last week's voluntary recall notice of Mylan Pharmaceuticals's Esme-28 oral contraceptives as a precaution followed the company's recall last month of its Freya-28 birth control pills across Canada after a pharmacy reported a placebo pill was misplaced in one package. In April, Apotex said one lot of its Alysena 28 contained an extra week of placebo pills.

Whether the issue occurs during production of brand name or generic drugs themselves, their packaging or labelling, "somewhere in there there is a weak link in the chain," Allan Malek, a senior vice-president at the Ontario Pharmacists Association, said Wednesday.

Doctors and pharmacists have concerns about how Health Canada handled a birth control recall. (Eric Gaillard/Reuters)

After the Alysena 28 recall, the Society of Obstetricians and Gynaecologists of Canada and the College of Family Physicians of Canada expressed concerns to Health Canada about how the recall was handled.

"We can't have people questioning the integrity of our drug system," Malek said. "That's where Health Canada comes in. They are the ones that have assumed the responsibility for approval ofmedications in this country. If that's their mandate then they ought to live up to and they need to ensure that theywork with the manufacturers to re-establish confidence in our system."

In April, then health minister Leona Aglukkaq said her ministry was looking into whether processes were followed and sufficient.

The obstetricians group also raised concerns that women could confuse the name of the generic birth control, Alysena, with a brand name birth control, Alesse.

Malek said look-alike and sound-alike drug names are an important but separate issue from product integrity, which Health Canada also needs to address.

Drug name examples include:

  • Losec, used to inhibit acid reflux and Lasix, a diuretic. Both are brand name medications and happen to come in the same 20-milligram strength.
  • Celebrex, an anti-inflammatory and Celexa, an antidepressant.
  • Zantac for excess acid in the stomach versus Xanax for anxiety, which pharmacists saycan sound confusing, especially over the phone.

Health Canada has guidelines on look-alike and sound-alike names but these lack the force of regulations, Malek said.

With files from CBC's Amina Zafar